Surging Demand for Estrogen Patches Triggers Shortages in Menopause Care
Demand for estrogen patches has surged after the FDA removed the boxed warning on hormone replacement therapy, outpacing supply and causing backorders and shortages. Clinics report long waitlists and patients must often switch brands or formulations, even though patches remain a preferred, lower-risk option due to insurance coverage and reduced clot risk.